Position
Chief Scientific Officer
Company
Asklepios BioPharmaceutical
Research Triangle ParkBiotechnologyHealth CareDescription
Asklepios BioPharmaceutical, the wholly-owned but independently operated subsidiary of Bayer, has appointed Mansuo Shannon new chief scientific officer. The company focuses on using gene therapy technology to develop life-saving medicines in a range of therapy areas.
Quick answer
Asklepios BioPharmaceutical Appoints Mansuo Shannon Chief Scientific Officer (April 9, 2024). Asklepios BioPharmaceutical is based in Research Triangle Park, North Carolina, United States.
- Who is the new Chief Scientific Officer at Asklepios BioPharmaceutical?
- Asklepios BioPharmaceutical named Mansuo Shannon Chief Scientific Officer, announced April 9, 2024.
- What did Asklepios BioPharmaceutical announce on April 9, 2024?
- Asklepios BioPharmaceutical, the wholly-owned but independently operated subsidiary of Bayer, has appointed Mansuo Shannon new chief scientific officer. The company focuses on using gene therapy technology to develop life-saving medicines in a range of therapy areas.
- What does Asklepios BioPharmaceutical do?
- Asklepios BioPharmaceutical, also known as AskBio, is a wholly-owned but independently operated subsidiary of Bayer (BAYN: DE).
- Where is Asklepios BioPharmaceutical based?
- Asklepios BioPharmaceutical is based in Research Triangle Park, North Carolina, United States.
- Which similar companies made leadership changes around the same time?
- HealthTrackRx (April 9, 2024), Xencor (April 9, 2024), Factor Bioscience (April 9, 2024) and Ferring Pharmaceuticals (April 9, 2024) also announced leadership changes within 45 days of Asklepios BioPharmaceutical.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- HealthTrackRx Appoints Steven Goldberg as Chief Medical Officer (April 9, 2024)
- Xencor Appoints Bart Cornelissen as Senior Vice President and Chief Financial Officer (April 9, 2024)
- Factor Bioscience Adds Kyle Garland, Ph.D. as Director of Translational Science (April 9, 2024)
- Ferring Pharmaceuticals Appoints Pierre-Yves Berclaz as Chief Medical Officer and Cyril Grandchamp-Desraux as Chief Commercial Officer (April 9, 2024)
- Castle Biosciences Names Frank Stokes as Chief Financial Officer (April 10, 2024)
- Arcutis Biotherapeutics Appoints David Topper as Chief Financial Officer (April 10, 2024)
Who to call at Asklepios BioPharmaceutical, and when
A new leader at Asklepios BioPharmaceutical brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Asklepios BioPharmaceutical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Asklepios BioPharmaceutical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Asklepios BioPharmaceutical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Asklepios BioPharmaceutical changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Asklepios BioPharmaceutical changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.